news
Latest News
Nov 12, 2024
Serranator Webinar November 2024
Oct 3, 2024
It's Time for a New Standard of Care: Addressing PAD with Serration Technology
Jun 11, 2024
Innovation with Serration: Serranator featured in Endovascular Today
May 7, 2024
Cagent Vascular appoints Chairman Brian Walsh to expanded role as Chief Executive Officer
Feb 20, 2024
Cagent Vascular Raises $30 Million Series C Financing
Jul 11, 2023
Cagent Vascular announces initial RECOIL Study results
Jun 7, 2023
Study finds Serranator serration balloon safe and effective in pedal arteries
May 31, 2023
Serranator Featured in Cath Lab Digest
May 31, 2023
Endovascular Today: Using Serranator® in Challenging CLTI Cases
Jan 31, 2023
Superior lumen gain, greater volumetric blood flow using Serranator: A sub-analysis of the PRELUDE BTK Study
Nov 30, 2021
Publication of the PRELUDE-BTK Study
Jun 17, 2021
Sectoral Asset Management Makes $9M Investment into Cagent Vascular
/news/its-time-for-a-new-standard-of-care-addressing-pad-with-serration-technology/news/innovation-with-serration-serranator-featured-in-endovascular-today/news/cagent-vascular-appoints-chairman-brian-walsh-to-expanded-role-as-chief-executive-officer/news/cagent-vascular-raises-30-million-series-c-financing/news/cagent-vascular-announces-initial-recoil-study-results/news/study-finds-serranator-serration-balloon-safe-and-effective-in-pedal-arteries/news/serranator-featured-in-cath-lab-digest/news/endovascular-today-using-serranator-in-challenging-clti-cases/news/superior-lumen-gain-greater-volumetric-blood-flow-using-serranator-a-sub-analysis-of-the-prelude-btk-study/news/cagent-vascular-announces/news/sectoral-asset-management/news/prelude-btk-study-results/news/limb-salvage-issue/news/endovascular-today/news/serranator-device/news/prelude-btk/news/chairman-of-the-board/news/ce-mark/news/cagent-vascular-completes-enrollment-of-prelude-study-using-serranator-device